rs199792389

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2

The NM_000292.3(PHKA2):​c.1493C>T​(p.Pro498Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000247 in 1,190,422 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 93 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00026 ( 0 hom. 88 hem. )

Consequence

PHKA2
NM_000292.3 missense

Scores

11
5
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 9.82
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.955
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PHKA2NM_000292.3 linkuse as main transcriptc.1493C>T p.Pro498Leu missense_variant 15/33 ENST00000379942.5 NP_000283.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PHKA2ENST00000379942.5 linkuse as main transcriptc.1493C>T p.Pro498Leu missense_variant 15/331 NM_000292.3 ENSP00000369274 P1
PHKA2ENST00000464455.1 linkuse as main transcriptn.62C>T non_coding_transcript_exon_variant 2/33

Frequencies

GnomAD3 genomes
AF:
0.000108
AC:
12
AN:
111419
Hom.:
0
Cov.:
22
AF XY:
0.000149
AC XY:
5
AN XY:
33623
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000226
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000709
AC:
13
AN:
183417
Hom.:
0
AF XY:
0.0000442
AC XY:
3
AN XY:
67855
show subpopulations
Gnomad AFR exome
AF:
0.000152
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000134
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000261
AC:
282
AN:
1079003
Hom.:
0
Cov.:
27
AF XY:
0.000254
AC XY:
88
AN XY:
346025
show subpopulations
Gnomad4 AFR exome
AF:
0.0000767
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000332
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.000108
AC:
12
AN:
111419
Hom.:
0
Cov.:
22
AF XY:
0.000149
AC XY:
5
AN XY:
33623
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000226
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000153
Hom.:
6
Bravo
AF:
0.000125
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.000382
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disease IXa1 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 16, 2022ClinVar contains an entry for this variant (Variation ID: 526622). This missense change has been observed in individual(s) with glycogen storage disease (PMID: 17689125, 28283841, 34117828). This variant is present in population databases (rs199792389, gnomAD 0.02%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 498 of the PHKA2 protein (p.Pro498Leu). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHKA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 28, 2022Variant summary: PHKA2 c.1493C>T (p.Pro498Leu) results in a non-conservative amino acid change located in the GH15-like domain (IPR011613) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.1e-05 in 183417 control chromosomes, including 3 hemizygotes. c.1493C>T has been reported in the literature in individuals affected with Glycogen Storage Diseases (e.g. Beauchamp_2007, Bali_2017, Benner_2021). The variant was also seen in three male hemizygous individuals from one family: two brothers affected with severe ketotic hypoglycemia as infants and one clinically unaffected uncle (Benner_2021). The variant was also seen in 4 female carriers, including the probands mother who had mild hypoglycemia and three unaffected female cousins born from the unaffected hemizygotic uncle. This pedigree does provide unequivocal evidence for or against causality. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: all have classified the variant as of uncertain significance. Based on the evidence outlined above, the variant was classified as VUS. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 28, 2022The c.1493C>T (p.P498L) alteration is located in exon 15 (coding exon 15) of the PHKA2 gene. This alteration results from a C to T substitution at nucleotide position 1493, causing the proline (P) at amino acid position 498 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
PHKA2-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 21, 2024The PHKA2 c.1493C>T variant is predicted to result in the amino acid substitution p.Pro498Leu. This variant was reported in a male with suspected glycogen storage disease type IX (GSD IX) (Beauchamp et al 2007. PubMed ID: 17689125). Additionally, it has been observed in two male siblings with symptomatic ketotic hypoglycemia (Benner et al. 2021. PubMed ID: 34117828). This variant is reported in 0.015% of alleles in individuals of African descent in gnomAD, including >90 hemizygotes in the larger gnomAD v4.1 dataset (https://gnomad.broadinstitute.org/variant/X-18925744-G-A?dataset=gnomad_r4). While we suspect this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 29, 2020In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17689125, 18950708) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.59
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.92
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.69
D
MetaRNN
Pathogenic
0.96
D
MetaSVM
Pathogenic
0.99
D
MutationAssessor
Uncertain
2.8
M
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.78
T
PROVEAN
Pathogenic
-7.0
D
REVEL
Pathogenic
0.92
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.038
D
Polyphen
1.0
D
Vest4
0.97
MVP
0.95
MPC
0.78
ClinPred
0.83
D
GERP RS
5.9
Varity_R
0.65
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199792389; hg19: chrX-18943862; COSMIC: COSV66052166; API